Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-037311)

Filing Details

Accession Number:: 0001209191-18-037311
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-06-12 18:42:29
Reporting Period:: 2018-06-11

Accepted Time:: 2018-06-12 18:42:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1557746	Aclaris Therapeutics Inc.	ACRS	Pharmaceutical Preparations (2834)	460571712

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1654337	Kamil Ali-Jackson	C/O Aclaris Therapeutics, Inc. 640 Lee Road, Suite 200 Wayne PA 19087	Chief Legal Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-06-11	100	$20.00	82,536	No	4	S	Direct
Common Stock	Disposition	2018-06-12	4,900	$20.00	77,636	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the record holder of the securities on March 23, 2018.